Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-12 04:31:30 EDT

Explore

PostsPeople
LatestRanked
Load more
@newsmedical.bsky.socialSep 16, 2026, 1:46 AM

🌿 Tiny vesicles from cannabis roots show early promise fighting tumors in mice - could plant nanovesicles be the future of immunotherapy? 👀
www.news-medical.net/news/2026091... #Cancer #Immunotherapy #Cannabis

@vaccinologist.bsky.socialSep 15, 2026, 8:55 PM

New Icahn School of Medicine at Mount Sinai study shows that a subset of #pancreaticcancer cells can create fibrin-rich immune-protective niches via PAI1/PAI2, recruiting suppressive macrophages & excluding #Tcells - a new angle for pancreatic #cancer #immunotherapy www.linkedin.com/posts/drmelv...

@uoft-tcairem.bsky.socialSep 15, 2026, 1:44 PM

🫁 #AI Tool Successfully Predicts Outcomes of #Immunotherapy in #Lung #Cancer

www.newswise.com/articles/ai-...

#MedEd #AIinHealthcare #HealthAI #HealthTech

@uoft-tcairem.bsky.socialSep 15, 2026, 1:43 PM

🫁 #AI Tool Successfully Predicts Outcomes of #Immunotherapy in #Lung #Cancer

www.newswise.com/articles/ai-...

#MedX #MedTwitter #MedEd #AIinHealthcare #HealthAI #HealthTech

@imtadvances.bsky.socialSep 15, 2026, 1:20 PM

Submissions are still open for our CD40 turns 40 Special Collection, exploring four decades of CD40 biology and its impact on immunotherapy across cancer, autoimmunity, and more 🧬

Learn more about submitting here: vist.ly/5ihwy

#Immunology #Immunotherapy

@imtadvances.bsky.socialSep 15, 2026, 12:20 PM

This review explores the bottom-up development of LGR5-targeting immunotherapeutics, showing how a highly specific α‑LGR5 antibody can be adapted into multiple modalities

📖 Read more: vist.ly/5ihju

#Immunotherapy #CancerResearch #CARTcells #PrecisionMedicine #OpenAccess

Wnt pathway illustration with modulation by RSPO showing gene expression changes.
@discoveripo.bsky.socialSep 15, 2026, 8:04 AM

Electra Therapeutics, Inc. set an expected IPO date
Electra Therapeutics has set an expected IPO date of September 17, 2026, as it focuses on precision medicines for…
Biotech

#IPO #Biotech #BiologicalProductsNoDiagnostic #UnitedStates #IPONews #BiologicalProducts #Cancer #Immunotherapy

@monalisarout1701.bsky.socialSep 15, 2026, 6:46 AM

Gastric cancer advances outlined:
🔬 7.7% cancer deaths worldwide
🔬 69% cases in Asia, high incidence in minorities
🔬 5-year survival varies, 36.4% overall
🔬 HER2 and PD-L1 testing in metastatic cases

#GastricCancer #Oncology #Immunotherapy https://tnyp.me/mkzMBbpw/s

@materchemfront.rsc.orgSep 15, 2026, 4:44 AM

🔔 Research article by Wei Gu 𝘦𝘵 𝘢𝘭.

A high-entropy nanozyme-based photothermal-adjuvant in situ nanovaccine for potentiated tumor immunotherapy

🔗 doi.org/10.1039/d5qm...

#Nanozymes #Immunotherapy #Nanovaccines #Photothermal

@gmj-georgia.bsky.socialSep 14, 2026, 9:26 PM

🔬 Breakthrough in pediatric oncology: Phase 1 ReMIND trial shows engineered T cells targeting multiple tumor antigens are well tolerated and prod… #Clinicaltrial #CNStumors #EngineeredTcells #Immunotherapy #NatureMedicine #Clinicaltrial #CNStumors #EngineeredTcells #Immunotherapy #NatureMedicin…

@jem.orgSep 14, 2026, 8:30 PM

Explore our #cancer #Immunotherapy collection showcasing a broad range of topics, including the therapeutic potential of targeting cDC1, a strategy to harness the immunosuppressive potential of inhibitory receptors, targeting of inhibitory receptor agonists, and more:
👉 rupress.org/jem/collecti...

@megadoctornews.comSep 14, 2026, 7:56 PM

New AI Tool Accurately Predicts Lung Cancer Immunotherapy Results #ai #ArtificialIntelligence #cancer #CancerTreatment #immunotherapy #LungCancer https://megadoctornews.com/new-ai-tool-accurately-predicts-lung-cancer-immunotherapy-results/

@sigtrans-sttt.bsky.socialSep 14, 2026, 3:30 PM

Chenodeoxycholic acid restrains tumor growth and potentiates antitumor immunity via TGR5-dependent dendritic cell activation. This study highlights metabolic modulation as a promising strategy for #Cancer #Immunotherapy.

#STTT #OpenAccess: doi.org/10.1038/s413...

Chenodeoxycholic acid restrains tumor growth via TGR5-dependent type 1 dendritic cells cross-priming
@healthcare-europe.bsky.socialSep 14, 2026, 6:30 AM

In #glioblastoma, the order of treatments matters: a new #study shows that administering cell #immunotherapy before #surgery to remove a #brain tumour is significantly more effective than 🔄 the other way around. http://dlvr.it/TVSs9G

@0lsi.bsky.socialSep 14, 2026, 3:18 AM

Given alongside Keytruda, a standard cancer #immunotherapy drug, fewer of the patients relapsed and fewer of their cancers spread than for those on Keytruda alone. It's the first time an mRNA cancer vaccine has worked in a late-stage trial.

@gmj-georgia.bsky.socialSep 14, 2026, 1:27 AM

Breakthrough: Engineered T-cell therapy targeting three tumor proteins shows early survival gains in children with diffuse intrinsic pontine glioma (DIPG) and rel… #Braincancer #Celltherapy #Clinicaltrial #DIPG #Immunotherapy #Braincancer #Celltherapy #Clinicaltrial #DIPG #Immunotherapy https:…

@tenuretracker.bsky.socialSep 14, 2026, 12:56 AM

Centre National de la Recherche Scientifique is hiring:
Postdoctoral Researcher in Immunotherapy

#postdoc #biology #immunotherapy

@aslamhdfdjygyv.bsky.socialSep 13, 2026, 8:36 PM

What if the next generation of cancer therapies comes from understanding how proteins interact—not just looking at individual proteins?

Read the open-access paper in Nature: www.nature.com/articles/s41...

#CancerResearch #Biotechnology #DrugDiscovery #Oncology #Immunotherapy

@breastcancerorg.bsky.socialSep 13, 2026, 7:06 PM

#Keytruda is a type of #immunotherapy called an immune checkpoint inhibitor. It may be prescribed for some people with triple-negative breast cancer, as well as some metastatic or inoperable breast cancers with specific biomarkers, including MSI-H, dMMR, or TMB-H.

Read more: https://bit.ly/4ipejwL

@drtimos.bsky.socialSep 12, 2026, 2:58 PM

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TVRwF2
@ASCO

#SocialListening #LucidQuest